Three World-Renowned Neurosurgeons Join Faculty At NYU Langone Medical Center

Chandranath Sen, Noel Perin and Howard Riina Add Breadth, Depth and Expertise in Skull Base Surgery, Brain Tumors, Disorders of the Spine, Cerebrovascular Neurosurgery, Interventional Neuroradiology and Stroke

March 23, 2011 (All day)

Chandranath Sen, MD; Noel Perin, MD, FRCS (Ed), FACS; and Howard Riina, MD, FACS, have joined the faculty of the Department of Neurosurgery at NYU Langone Medical Center, which has been recognized as one of the top ten hospitals in the country for neurology and neurosurgery by U.S. News & World Report for the past three years.

“We are excited to have the exceptional skills of Drs. Sen, Perin and Riina added to our extraordinary team,” said John G. Golfinos, MD, professor and chair, Department of Neurosurgery, NYU Langone Medical Center. “As leaders in their fields, their individual neurosurgical expertise expands and complements our existing strengths and enhances our ability to successfully treat the most complex cases.”

Chandranath Sen, MD, is the new director of the Benign Brain Tumor and Cranial Nerve Disorders Programs at NYU Langone. He specializes in skull base tumor surgery, which encompasses the surgical treatment of a variety of tumors such as cranial nerve schwannomas, pituitary tumors, craniopharyngiomas, glomus tumors, meningiomas, chordomas and chondrosarcomas, as well as paranasal sinus tumors that invade the base of the skull. He is also experienced in the surgery for trigeminal neuralgia, glossopharyngeal neuralgia and hemifacial spasm. Prior to coming to NYU Langone, Dr. Sen was chairman of neurosurgery at Roosevelt Hospital in Manhattan for ten years, and before that was vice chairman, Department of Neurosurgery at Mt. Sinai Medical Center for ten years. He completed fellowships at the University of Pittsburgh (microneurosurgery) and the National Hospitals for Nervous Disorders in London. Dr. Sen is a member of the American Association of Neurological Surgeons, a founding member of the North American Skull Base Society, and a current member and former president of the New York Society of Neurosurgery.

Noel Perin, MD, FRCS (Ed), FACS, will serve as the director of minimally invasive spinal neurosurgery at NYU Langone, with a focus on advancing minimally invasive surgical techniques, the treatment of complex disorders of the spine, spine and spinal cord tumors and peripheral nerve disorders. He is one of the few neurosurgeons to perform thoracoscopic discectomies, resections of thoracic paravertebral schwannomas and neurofibromas, and sympathectomy for hyperhidrosis (a condition where the body perspires far more than necessary to regulate the body’s temperature.) Before coming to NYU Langone, Dr. Perin was the director of the Center for Spine and Minimally Invasive Surgery in the Department of Neurosurgery at St. Luke’s-Roosevelt Hospital Center. He completed his residency in neurosurgery and fellowships in neuro/ortho, both at NYU Langone Medical Center, and a fellowship in complex cervical spine surgery in Osnerbruk, West Germany. He is a member of the American Board of Neurological Surgeons, American College of Surgeons as well as the Royal College of Surgeons in Edinburgh, Scotland.

Howard A. Riina, MD, FACS, is a cerebrovascular and endovascular neurosurgeon and leading expert in the treatment of intracranial aneurysms, carotid occlusive disease, vascular malformations of the brain and spine and stroke. He is one of a few internationally recognized neurosurgeons who perform both open micro-cerebrovascular neurosurgery and interventional neuroradiology. Dr. Riina comes from Weill Cornell Medical College/New York Presbyterian Hospital, where he served as professor of neurological surgery, co-director of neuroendovascular services/interventional neuroradiology and director of the Neurological Surgery Residency Training Program. He received his neurological surgery training at the Hospital of the University of Pennsylvania and completed fellowships in diagnostic neuroradiology at the Hospital of the University of Pennsylvania, endovascular-interventional neuroradiology at the Institute of Neurology and Neurosurgery of Beth Israel Medical Center and cerebrovascular/skull base surgery at the Barrow Neurological Institute in Phoenix. Dr Riina has lectured and published extensively on intracranial aneurysms and vascular malformations of the brain and spine. He is a member of the American Academy of Neurological Surgeons, the Society of Neurological Surgeons, the American Association of Neurological Surgeons and the American College of Surgeons.

NYU Langone Medical Center’s Department of Neurosurgery is headed by John Golfinos, MD, who joined NYU School of Medicine in 1995 as an expert in acoustic neuromas, metastatic brain tumors, skull base tumors and neurofibromatosis. An award-winning researcher specializing in diagnostic and outcomes investigations, Dr. Golfinos completed his residency and chief residency in neurosurgery and a fellowship in molecular biology research at the Barrow Neurological Institute in Phoenix, Arizona.

The Department of Neurosurgery was established 60 years ago when Thomas I. Hoen, a Johns Hopkins, Brigham Hospital and Royal Victoria Hospital-trained surgeon and neurosurgeon, initiated the academic department and formal training program in neurological surgery. Today, the Department of Neurosurgery has more than 20 full-time faculty specializing in the research and treatment of conditions impacting the brain and nervous system, from head and spinal cord injuries to subarachnoid hemorrhage and vasospasm, intracranial tumors and postoperative adjuvant therapy, glial tumor biology and minimally invasive approaches to intracranial neoplasms by computer-assisted stereotactic methods. As part of a large academic medical institution, research plays a critical role in developing the techniques and treatments for the advancement of care. In 2010, Dimitris Placantonakis, MD, PhD, a specialist in gliomas, metastatic disease and sellar/parasellar tumors, came to NYU Langone to expand research in brain tumors and other areas such as conditions of the spine and epilepsy. For more information go to

Media Inquiries:

Craig Andrews

212-404-3511 |